Argent Biopharma Ltd has released a press release.
US Veterinary Development Programme for CannEpil Commences
Earlier from Argent Biopharma
- CannEpil Global Licence Expands into Veterinary Healthcare
- RGT Executes Global CannEpil Licensing Deal for US$5.5M
- Half Yearly Report and Accounts
- Provisional Patent Lodged with USPTO for NanoBodies Platform